199 related articles for article (PubMed ID: 25886453)
1. Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms.
Wang H; Yang S; Zhou H; Sun M; Du L; Wei M; Luo M; Huang J; Deng H; Feng Y; Huang J; Zhou Y
J Hematol Oncol; 2015 Mar; 8():26. PubMed ID: 25886453
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Antitumor Activity of Aloperine on Human Thyroid Cancer Cells through Caspase-Dependent Apoptosis.
Lee YR; Chen SH; Lin CY; Chao WY; Lim YP; Yu HI; Lu CH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361731
[TBL] [Abstract][Full Text] [Related]
3. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
4. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF.
Ding JH; Yuan LY; Huang RB; Chen GA
Eur J Haematol; 2014 Oct; 93(4):329-39. PubMed ID: 24766194
[TBL] [Abstract][Full Text] [Related]
5. Fucoidan inhibits angiogenesis induced by multiple myeloma cells.
Liu F; Luo G; Xiao Q; Chen L; Luo X; Lv J; Chen L
Oncol Rep; 2016 Oct; 36(4):1963-72. PubMed ID: 27498597
[TBL] [Abstract][Full Text] [Related]
6. Autophagy Modulation in Human Thyroid Cancer Cells following Aloperine Treatment.
Yu HI; Shen HC; Chen SH; Lim YP; Chuang HH; Tai TS; Kung FP; Lu CH; Hou CY; Lee YR
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731481
[TBL] [Abstract][Full Text] [Related]
7. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma.
Yokokura S; Yurimoto S; Matsuoka A; Imataki O; Dobashi H; Bandoh S; Matsunaga T
BMC Cancer; 2014 Nov; 14():882. PubMed ID: 25424011
[TBL] [Abstract][Full Text] [Related]
9. Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner.
Huang J; Yang M; Liu H; Jin J
Acta Pharmacol Sin; 2008 Aug; 29(8):951-64. PubMed ID: 18664328
[TBL] [Abstract][Full Text] [Related]
10. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
[TBL] [Abstract][Full Text] [Related]
11. Antimyeloma effects of a sesquiterpene lactone parthenolide.
Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H
Clin Cancer Res; 2008 Mar; 14(6):1814-22. PubMed ID: 18347184
[TBL] [Abstract][Full Text] [Related]
12. Aloperine induces G2/M phase cell cycle arrest and apoptosis in HCT116 human colon cancer cells.
Zhang L; Zheng Y; Deng H; Liang L; Peng J
Int J Mol Med; 2014 Jun; 33(6):1613-20. PubMed ID: 24682388
[TBL] [Abstract][Full Text] [Related]
13. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
[TBL] [Abstract][Full Text] [Related]
14. Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents.
Leiba M; Jakubikova J; Klippel S; Mitsiades CS; Hideshima T; Tai YT; Leiba A; Pines M; Richardson PG; Nagler A; Anderson KC
Br J Haematol; 2012 Jun; 157(6):718-31. PubMed ID: 22533681
[TBL] [Abstract][Full Text] [Related]
15. The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.
Munugalavadla V; Mariathasan S; Slaga D; Du C; Berry L; Del Rosario G; Yan Y; Boe M; Sun L; Friedman LS; Chesi M; Leif Bergsagel P; Ebens A
Oncogene; 2014 Jan; 33(3):316-25. PubMed ID: 23318440
[TBL] [Abstract][Full Text] [Related]
16. Antitumor efficacy of lidamycin against human multiple myeloma RPMI 8226 cells and the xenograft in nonobese diabetic/severe combined immunodeficiency mice.
Zhen Y; Shang B; Liu X; Lin Y; Zhen Y
J Cancer Res Ther; 2016; 12(1):182-7. PubMed ID: 27072234
[TBL] [Abstract][Full Text] [Related]
17. Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models.
He D; Guo X; Zhang E; Zi F; Chen J; Chen Q; Lin X; Yang L; Li Y; Wu W; Yang Y; He J; Cai Z
Oncotarget; 2016 Jul; 7(29):45489-45499. PubMed ID: 27329589
[TBL] [Abstract][Full Text] [Related]
18. Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice.
Yuan XY; Liu W; Zhang P; Wang RY; Guo JY
Eur J Pharmacol; 2010 Mar; 629(1-3):147-52. PubMed ID: 20006963
[TBL] [Abstract][Full Text] [Related]
19. [Effect of total alkaloid of Sophora alopecuroides on SW480 cells and Balb/c nude mice tumor xenograft].
Jiao HL; Yao R; Deng HZ; Wang XJ; Yuan HX; Yao H
Zhong Yao Cai; 2011 Jul; 34(7):1090-3. PubMed ID: 22066406
[TBL] [Abstract][Full Text] [Related]
20. PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.
Yang C; Huang X; Liu H; Xiao F; Wei J; You L; Qian W
Oncotarget; 2017 Jun; 8(24):39185-39197. PubMed ID: 28402933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]